Immuron Limited (IMRN): Price and Financial Metrics
Immuron Limited (IMRN)
Today's Latest Price: $2.12 USD
0.02 (0.95%)
Updated May 29 12:01pm
Add IMRN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 214 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
IMRN Stock Summary
- IMRN has a market capitalization of $8,568,825 -- more than approximately merely 5.15% of US stocks.
- For IMRN, its debt to operating expenses ratio is greater than that reported by merely 0.34% of US equities we're observing.
- With a year-over-year growth in debt of -100%, Immuron Ltd's debt growth rate surpasses only 0% of about US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Immuron Ltd are GIGM, ASYS, MTSL, MGIC, and JOUT.
- IMRN's SEC filings can be seen here. And to visit Immuron Ltd's official web site, go to www.immuron.com.
IMRN Daily Price Range
IMRN 52-Week Price Range
IMRN Stock Price Chart More Charts
IMRN Price/Volume Stats
| Current price | $2.12 | 52-week high | $7.25 |
| Prev. close | $2.10 | 52-week low | $1.55 |
| Day low | $2.12 | Volume | 936 |
| Day high | $2.15 | Avg. volume | 19,628 |
| 50-day MA | $2.11 | Dividend yield | N/A |
| 200-day MA | $3.00 | Market Cap | 7.59M |
Immuron Limited (IMRN) Company Bio
Immuron Limited focuses on developing and commercializing oral immunotherapeutics for the treatment of various gut medicated diseases in Australia and internationally. The company operates through Research and Development, and HyperImmune Products segments. The company was founded in 1994 and is based in Australia.
Loading social stream, please wait...